SPINAL MUSCULAR ATROPHY Market Trends
May 27, 2019
Meet the World’s most expensive drug: Zolgensma
The U.S. FDA recently approved the much talked about Novartis’s drug Zolgensma for treating a life-threatening condition Spinal Muscular Atrophy (SMA). SMA is a neuromuscular disorder that worsens the muscles over time. It happens due to a mutation in the SMN1 gene that results in the deficiency of an SMN protein,...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
